Omnicell, Inc. (NASDAQ:OMCL)

CAPS Rating: 5 out of 5

The Company is a provider of medication control and patient safety solutions for acute care health facilities.

Recs

0
Player Avatar evillate (< 20) Submitted: 5/10/2008 12:17:53 AM : Outperform Start Price: $13.53 OMCL Score: +2.95

Growth rate is slow but in the long term this should be ok. Nothing special here. PE is half what it should be but this is related to the growth rate. I like this as a turtle in the race.

Featured Broker Partners


Advertisement